Poster: Enabling Real-Time Analytics in Clinical Trials

Topic:

Format:

Building an AI-Ready Clinical Data Platform

About the poster

Ryvu Therapeutics, in collaboration with Ardigen, transitioned from traditional data silos to a unified, AI-ready platform using the Databricks Lakehouse for Clinical Trials Management. The key drivers behind this transformation like near real-time analytics, scalable data integration, and AI readiness are explored. The solution unifies diverse clinical datasets, ensures regulatory compliance, and leverages cloud-based scalability across AWS, GCP, and Azure. This case study showcases how modern data architectures empower clinical teams and senior management to make faster, data-driven decisions while laying the groundwork for AI innovations in clinical research.

This poster was originally presented during the BioIT 2025 Conference.

You might be also interested in:

Blog cover for Ardigen publication on ARDisplay-I and MHC ligand identification in Molecular & Cellular Proteomics
New publication in MCP: Improving MHC ligand identification with machine learning and optimized isolation
Fluorescence microscopy image of cells stained with multiple Cell Painting dyes showing cellular organelles in green, blue, and pink, overlaid with Ardigen brand graphic elements indicating phenomics data in durg discovery
End to End Data-to-Decision Journey for AI-Driven Phenomics in Drug Discovery
Abstract network visualization representing AI-driven integration of biological data and knowledge graphs for target identification in drug discovery.
Target Identification: From Poor Data to Quality Predictions
Abstract data streams representing data sourcing in pharmaceutical research and AI drug discovery
What Are Common Data Sourcing Patterns in Pharmaceutical Research (part 3)

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!